On Friday, Biodesix Inc (NASDAQ: BDSX) opened higher 6.98% from the last session, before settling in for the closing price of $0.42. Price fluctuations for BDSX have ranged from $0.17 to $2.04 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 69.26% annually for the last half of the decade. Company’s average yearly earnings per share was noted 18.44% at the time writing. With a float of $69.38 million, this company’s outstanding shares have now reached $146.58 million.
Biodesix Inc (BDSX) Insider Updates
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of Biodesix Inc is 52.69%, while institutional ownership is 24.29%. The most recent insider transaction that took place on Aug 13 ’25, was worth 411. In this transaction CFO, Sec’y & Treasurer of this company sold 988 shares at a rate of $0.42, taking the stock ownership to the 250,794 shares. Before that another transaction happened on Aug 13 ’25, when Company’s President & CEO sold 3,772 for $0.42, making the entire transaction worth $1,570. This insider now owns 728,824 shares in total.
Biodesix Inc (BDSX) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.07 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.08) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 18.44% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.73% during the next five years compared to 69.26% growth over the previous five years of trading.
Biodesix Inc (NASDAQ: BDSX) Trading Performance Indicators
Check out the current performance indicators for Biodesix Inc (BDSX). In the past quarter, the stock posted a quick ratio of 2.03. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.87.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.28, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.17 in one year’s time.
Technical Analysis of Biodesix Inc (BDSX)
Let’s dig in a bit further. During the last 5-days, its volume was 0.94 million. That was inferior than the volume of 3.9 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 80.58%.
During the past 100 days, Biodesix Inc’s (BDSX) raw stochastic average was set at 48.80%, which indicates a significant decrease from 80.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0452 in the past 14 days, which was lower than the 0.0481 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3450, while its 200-day Moving Average is $0.7564. However, in the short run, Biodesix Inc’s stock first resistance to watch stands at $0.4722. Second resistance stands at $0.4910. The third major resistance level sits at $0.5221. If the price goes on to break the first support level at $0.4223, it is likely to go to the next support level at $0.3912. Assuming the price breaks the second support level, the third support level stands at $0.3724.
Biodesix Inc (NASDAQ: BDSX) Key Stats
There are currently 146,633K shares outstanding in the company with a market cap of 66.48 million. Presently, the company’s annual sales total 71,320 K according to its annual income of -42,930 K. Last quarter, the company’s sales amounted to 20,020 K and its income totaled -11,470 K.
